Recent Information: Three-Year Duration of Immunity Challenge Studies*

Introduction

Fort Dodge completed a long-term vaccination challenge study to determine if three main canine antigens,canine distemper virus (CDV),canine adenovirus type 2 (CAV-2) and canine parvovirus (CPV),protected for three years. These studies were conducted under strictly controlled laboratory conditions to ensure the best possible evaluation of the product. The dogs in this study were isolated during the entire study period to eliminate any possible outside influences on their response to challenge. Study Design

A group of 40 SPF healthy puppies were used in the study. Vaccinates received two doses of Duramune® Adult; one at six weeks of age and a second dose at nine weeks of age.All dogs were housed in isolation facilities and were under veterinary care for the duration of the study. Controls and vaccinates were housed in separate isolation facilities during the immunization period and until they were challenged to prevent exposure to vaccine virus shedding.

Method:

Number of Dogs Participating
CDVCAV-2CPVTotal
IM vaccinates53513
SC vaccinates59519
Unvaccinated controls3238
Total13141340
Virus challenge was conducted three years after the second vaccination was administered. Dogs were evaluated for clinical signs for a period of time post challenge. Each clinical sign was assigned a score based on its severity.The results are shown below.

*Published in International Journal of Applied Research in Veterinary Medicine,Vol.2,No.4,2004.



cdv

Canine distemper virus:

Severe clinical signs include:

  • Mucopurulent ocular discharge
  • Severe conjunctivitis
  • Seizures/convulsions
  • Death


cav-2

Infectious canine hepatitis virus:

Severe clinical signs include:

  • Conjunctivitis
  • Severe ocular discharge
  • Severe nasal discharge
  • Abdominal hemorrhages


cpv

Canine parvovirus:

Severe clinical signs include:*

  • Mucous, watery or bloody stools
  • Anorexia
  • Lethargy/Depression
  • Dehydration
  • Coughing
  • Vomiting

* Clinical disease in adult dogs is less severe


Studies

Adjuvants

Vaccine adjuvants are chemical proteins that enhance the immune response to vaccine antigens. more

AVMA Position

The AVMA Council on Biologic and Therapeutic Agents (COBTA) has thoroughly reviewed information on dog and cat vaccines and has issued two reports: 1. Principles of Vaccination - JAVMA Sept. 1, 2001 2.Report on Cat and Dog Vaccines - JAVMA Nov. 15, 2002 more

AAHA Canine Vaccination Guidelines

Limited published scientific information exists on duration of immunity. Therefore, these guidelines and recommendations are based on limited scientific evidence but are supported by consensus and expert opinion, as well as clinical evidence.more

AAFP Feline Vaccination Guidelines

Extended vaccination intervals recommended in the 2000 Report of the American Association of Feline Practitioners (AAFP) and Academy of Feline Medicine Advisory Panel on Feline Vaccines referenced a foundation study conducted by Dr. Fred Scott. more

Killed vs. Modified-Live Vaccines

For some antigens, veterinarians have to decide whether to use a killed vaccine or a modified-live vaccine. Each vaccine has its advantages, and each has its disadvantages. more

Recent Information: Three-Year Duration of Immunity Challenge Studies

Fort Dodge completed a long-term vaccination challenge study to determine if three main canine antigens,canine distemper virus (CDV),canine adenovirus type 2 (CAV-2) and canine parvovirus (CPV),protected for three years. more

Sarcomas

In 1996, the Vaccine Associated Feline Sarcoma Task Force was formed with the mission of determining the cause of sarcomas in cats. more

The Important Role of Vaccine Adjuvants

Adjuvants are agents designed to stimulate the immune response to vaccine antigens. more

Void where prohibited. Although the information on this site is accessible worldwide, not all products or services discussed in this site are available to all persons or in all geographic locations or jurisdictions. All companies reserve the right to limit provision of products or services to any person, geographic region or jurisdiction and/or to limit the quantities of any products or services they provide. Any offer for any product or service made in the materials on this site is void where prohibited